855-27045-95975
3 vaccinations
2 coded responses
4 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 208 / MD
- Registered
- 2022-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2022-01-22
Dose 3 — Pfizer-BioNTech
-
2022-01-23
Registered in v-safe
-
2022-01-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Nausea, VomitingAdult check-in
-
2022-01-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2022-01-25
Survey response — days 1–6 daily, dose 3MedDRA: Chest discomfort — Feeling: FairFree text: Chest tightnessMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Survey response — days 1–6 daily, dose 3MedDRA: Chest discomfort — Feeling: FairFree text: Chest tightnessMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | No |
| 2 | 2021-02-20 | Pfizer-BioNTech | No |
| 3 | 2022-01-22 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Chest tightness
Systemic reaction (other): Chest tightness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chest discomfort | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release